| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $1,643,749 | 5 | 10 |
Sells | $15,103,872 | 44 | 90 |
| BAKER BROS. ADVISORS LP | 10 percent owner | 4 | $1.61M | 0 | $0 | $1.61M |
| Zeiher Bernhardt G | director | 1 | $29,316 | 0 | $0 | $29,316 |
| Sethuraman Natarajan | President, Research & Develop. | 0 | $0 | 1 | $398,810 | $-398,810 |
| Dowden Nathan J | President & COO | 0 | $0 | 3 | $425,724 | $-425,724 |
| WENTWORTH KORY JAMES | Chief Financial Officer | 0 | $0 | 5 | $433,577 | $-433,577 |
| 5AM Ventures V, L.P. | 10 percent owner | 0 | $0 | 5 | $3M | $-3M |
| MPM BioVentures 2014, L.P. | 10 percent owner | 0 | $0 | 12 | $3.6M | $-3.6M |
| MPM BIOVENTURES 2018, L.P. | 10 percent owner | 0 | $0 | 12 | $3.6M | $-3.6M |
| PARMAR KUSH | 0 | $0 | 6 | $3.65M | $-3.65M |
Entrada Therapeutics, Inc. operates as a biotechnology enterprise dedicated to pioneering endosomal escape vehicle (EEV) therapeutics, specifically engineered to tackle a range of neuromuscular ailments. The company leverages its proprietary EEV platform to cultivate a rich pipeline of therapeutic programs, integrating oligonucleotide, antibody, and enzyme-based approaches. Its foremost product candidate, ENTR-601-44, is currently undergoing preclinical assessment for its potential in addressing both Duchenne muscular dystrophy and myotonic …
Over the last 12 months, insiders at Entrada Therapeutics, Inc. have bought $1.64M and sold $15.1M worth of Entrada Therapeutics, Inc. stock.
On average, over the past 5 years, insiders at Entrada Therapeutics, Inc. have bought $1.29M and sold $5.42M worth of stock each year.
Highest buying activity among insiders over the last 12 months: BAKER BROS. ADVISORS LP (10 percent owner) — $1.61M. Zeiher Bernhardt G (director) — $29,316.
The last purchase of 5,000 shares for transaction amount of $29,316 was made by Zeiher Bernhardt G (director) on 2026‑05‑20.
| 2026-09-09 | Sale | MPM BIOVENTURES 2018, L.P. | 10 percent owner | 28,837 0.0745% | $7.13 | $205,608 | -22.64% | |
| 2026-09-09 | Sale | MPM BioVentures 2014, L.P. | 10 percent owner | 28,837 0.0745% | $7.13 | $205,608 | -22.64% | |
| 2026-09-08 | Sale | MPM BIOVENTURES 2018, L.P. | 10 percent owner | 192,500 0.4493% | $7.41 | $1.43M | -26.66% | |
| 2026-09-08 | Sale | MPM BioVentures 2014, L.P. | 10 percent owner | 192,500 0.4493% | $7.41 | $1.43M | -26.66% | |
| 2026-09-04 | Sale | MPM BIOVENTURES 2018, L.P. | 10 percent owner | 38,500 0.0909% | $7.11 | $273,735 | -22.44% | |
| 2026-09-04 | Sale | MPM BioVentures 2014, L.P. | 10 percent owner | 38,500 0.0909% | $7.11 | $273,735 | -22.44% | |
| 2026-09-03 | Sale | MPM BIOVENTURES 2018, L.P. | 10 percent owner | 32,263 0.0831% | $7.17 | $231,326 | -22.32% | |
| 2026-09-03 | Sale | MPM BioVentures 2014, L.P. | 10 percent owner | 32,263 0.0831% | $7.17 | $231,326 | -22.32% | |
| 2026-09-02 | Sale | MPM BIOVENTURES 2018, L.P. | 10 percent owner | 25,131 0.0638% | $7.19 | $180,692 | -23.15% | |
| 2026-09-02 | Sale | MPM BioVentures 2014, L.P. | 10 percent owner | 25,131 0.0638% | $7.19 | $180,692 | -23.15% | |
| 2026-09-01 | Sale | MPM BIOVENTURES 2018, L.P. | 10 percent owner | 29,088 0.0748% | $7.06 | $205,361 | -20.23% | |
| 2026-09-01 | Sale | MPM BioVentures 2014, L.P. | 10 percent owner | 29,088 0.0748% | $7.06 | $205,361 | -20.23% | |
| 2026-08-31 | Sale | MPM BIOVENTURES 2018, L.P. | 10 percent owner | 44,259 0.1039% | $6.99 | $309,370 | -19.57% | |
| 2026-08-31 | Sale | MPM BioVentures 2014, L.P. | 10 percent owner | 44,259 0.1039% | $6.99 | $309,370 | -19.57% | |
| 2026-08-28 | Sale | MPM BIOVENTURES 2018, L.P. | 10 percent owner | 3,733 0.0089% | $7.01 | $26,168 | -18.93% | |
| 2026-08-28 | Sale | MPM BioVentures 2014, L.P. | 10 percent owner | 3,733 0.0089% | $7.01 | $26,168 | -18.93% | |
| 2026-08-27 | Sale | MPM BIOVENTURES 2018, L.P. | 10 percent owner | 38,922 0.0913% | $7.20 | $280,238 | -21.87% | |
| 2026-08-27 | Sale | MPM BioVentures 2014, L.P. | 10 percent owner | 38,922 0.0913% | $7.20 | $280,238 | -21.87% | |
| 2026-08-26 | Sale | MPM BIOVENTURES 2018, L.P. | 10 percent owner | 14,569 0.0379% | $7.06 | $102,857 | -15.43% | |
| 2026-08-26 | Sale | MPM BioVentures 2014, L.P. | 10 percent owner | 14,569 0.0379% | $7.06 | $102,857 | -15.43% |
| BAKER BROS. ADVISORS LP | 10 percent owner | 4691392 12.0488% | $22.14M | 12 | 0 | +124.37% |
| MPM BioVentures 2014, L.P. | 10 percent owner | 3885115 9.978% | $18.34M | 1 | 14 | <0.0001% |
| MPM BIOVENTURES 2018, L.P. | 10 percent owner | 3885115 9.978% | $18.34M | 1 | 14 | <0.0001% |
| 5AM Ventures V, L.P. | 10 percent owner | 2783781 7.1495% | $13.14M | 1 | 9 | <0.0001% |
| PARMAR KUSH | director | 2691337 6.9121% | $12.7M | 1 | 10 | <0.0001% |
| Zeiher Bernhardt G | director | 5000 0.0128% | $23,600.00 | 1 | 0 | |
| Baker Bros. Advisors (GP) LLC | 4475208 11.4936% | $21.12M | 3 | 0 | +129.14% | |
| Foley Todd | 4425784 11.3666% | $20.89M | 1 | 0 | <0.0001% | |
| Redmile Group, LLC | 10 percent owner | 1954420 5.0195% | $9.22M | 1 | 0 | <0.0001% |
| KIM PETER S | director | 117412 0.3015% | $554,184.64 | 12 | 0 | +11.26% |
| Crowley John F | director | 5000 0.0128% | $23,600.00 | 1 | 0 | +22.78% |
$6,788,859 | 35 | 26.72% | $151.54M | |
$7,147,964 | 34 | 24.77% | $166.39M | |
$38,621,826 | 31 | 1.43% | $157.74M | |
Entrada Therapeutics, Inc. (TRDA) | $74,231,875 | 30 | 40.62% | $183.78M |
$54,828,550 | 26 | -13.88% | $201.12M |
| Increased Positions | 52 | +38.24% | 3M | +9.52% |
| Decreased Positions | 57 | -41.91% | 2M | -7.46% |
| New Positions | 18 | New | 657,520 | New |
| Sold Out Positions | 15 | Sold Out | 285,531 | Sold Out |
| Total Postitions | 131 | -3.68% | 31M | +2.07% |
| Baker Bros. Advisors Lp | $48,901.00 | 12.81% | 4.87M | 0 | 0% | 2025-09-30 |
| Mpm Asset Management Llc | $44,030.00 | 11.53% | 4.38M | 0 | 0% | 2025-09-30 |
| 5Am Venture Management, Llc | $42,777.00 | 11.2% | 4.26M | -52,000 | -1.21% | 2025-09-30 |
| Blackrock, Inc. | $20,543.00 | 5.38% | 2.04M | +21,894 | +1.08% | 2025-09-30 |
| Merck & Co., Inc. | $17,485.00 | 4.58% | 1.74M | 0 | 0% | 2025-09-30 |
| Vanguard Group Inc | $16,122.00 | 4.22% | 1.6M | -635 | -0.04% | 2025-09-30 |
| Wellington Management Group Llp | $9,592.00 | 2.51% | 954,419 | -106,297 | -10.02% | 2025-09-30 |
| Millennium Management Llc | $8,408.00 | 2.2% | 836,609 | +666,287 | +391.19% | 2025-09-30 |
| Stepstone Group Lp | $7,651.00 | 2% | 761,277 | 0 | 0% | 2025-09-30 |
| Geode Capital Management, Llc | $6,483.00 | 1.7% | 645,119 | +13,565 | +2.15% | 2025-09-30 |